Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Content protection apparatus and content encryption and decryption apparatus using white-box encryption table
Reliable event broadcaster with multiplexing and bandwidth control functions
Method and devices for handling access privileges
Ascertaining presentation format based on device primary control determination
Integrated emergency medical database system
Method of manufacturing a plurality of electronic assemblies
Apparatus and method for manufacturing microneedles
  Randomly Featured Patents
Apparatus and method for reusing satellite broadcast spectrum for terrestrially broadcast signals
Method and system for deriving location information from utility lines
Biphenyl compounds and their use as oestrogenic agents
Infra-red domestic furnace
Oscillatory or translational table for machine tools
Zirconium alloy having high corrosion resistance and high strength
Translator for IP networks, network system using the translator, and IP network coupling method therefor
Method and apparatus for foam removal in an ink container
Self-leveling silicone sealant compositions and methods for making same